NAVITAS-WIND
2.2.2024 16:36:28 CET | Business Wire | Press release
As of February 1, 2024, Executive Partner Maciej Suchy and Executive Partner Adam Bartelik have joined the ownership circle of Navitas Wind A/S. The new co-owners bring solid knowledge and experience from the Renewable energy sector, thereby increasing Navitas Wind’s momentum in the International market.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240202857457/en/
The new ownership group and board of directors of Navitas Wind A/S. From left Maciej Suchy, Rene Kildsgaard, Martin Jacobsen, Kuno jacobsen, Glenn Aagesen and Adam Bartelik. (Photo: Business Wire)
Kuno Jacobsen, CEO of Navitas Wind A/S:
“Since our Start in 2019, we have devoted many internal resources to creating a robust foundation for Navitas Wind. Within the management team, we have focused on developing an organization with a strong, industrious drive and a professional mindset – for both customers and employees. Now we enter Navitas’ fifth year of existence and continue our growth journey together with Maciej and Adam. This will enable us, among other things, to develop the company’s competencies, expand our business area, and focus even more on international projects.”
Internationally Experienced Individuals from the Industry:
Short about Maciej Suchy
Extensive operational and commercial experience within the Wind Energy Sector, specialising in construction project management, sales, and business development and people management.
Maciej says: “I feel extremely lucky, thrilled and excited to join this enthusiastic organisation, where the Quality Service is achieved through an innovative Fun&Work approach. Where the PROUD and HAPPY team can only focus on delivering their BEST to the Customers’ satis- faction. How cool is that..? With humble respect, I am committed to doing my best in growing further the Navitas Company with all new innovative projects.”
Short about Adam Bartelik
Extensive operational and project engineering experience within the Wind Energy Sector, specialising in construction project management, new concepts development and people management.
Adam says: ”Passion, and challenges, not an easy business, can only be done with people with the same vision. Creating, developing and constantly improving the company so that everyone is proud to be part of it. This is what motivates me to work with Navitas with friends on a private and professional level. I can’t wait to help develop a company that meets the customer’s needs and is an ideal place to work for our employees. Let’s move to the next level.”
Navitas’s strategic decision to onboard Maciej and Adam is an important milestone in fortifying our corporate capabilities. It is essential for moving the company into its next phase of development. Our objective is to broaden our geographical reach and broaden the range of solutions we offer to our clients, positioning Navitas as an all-in-one hub, turn-key supplier, in the Renewable Energy sector.
Both Maciej and Adam bring a dynamic blend of drive and expertise, pivotal in supporting our ambitious journey. Their involvement in the strategic planning process, ensuring Navitas’s sustained growth and solidifying our position in the market.
The energy sector is facing a crucial industrialization phase internationally.
At Navitas, we believe that our efforts to integrate advanced technology and sustainable methods will be key to achieving a more sustainable future. By securing the future growth of Navitas Wind A/S and maintaining our high-quality level in the wind industry, we confidently move into a new and exciting phase of the company growth.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240202857457/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
From Network Automation to Agentic NetOps: NetBrain Sets the Standard for Deploying AI in Network Operations29.5.2026 15:00:00 CEST | Press release
Newest expansion of the NetBrain platform delivers Agent Skills, AI Path Doctor, MCP Server, and expanded cross-domain integrations, extending the agentic capabilities already running in production at hundreds of enterprises. NetBrain Technologies, Inc. today announced major new platform features that advance Agentic NetOps from an emerging category to operational reality. NetBrain's clients are already deploying agents that are diagnosing and remediating issues across complex multi-vendor enterprise networks. These new features further extend the platform with new agent tooling, cross-domain context, and open interfaces for the broader agentic enterprise. Early customer outcomes show the magnitude of the shift: A leading health insurer used NetBrain's Deep Diagnosis agent to diagnose and resolve a weeks old VPN connectivity issue in under five minutes. A large manufacturer resolved a critical device issue with a single prompt, isolating the root cause across the network path in under
Adtran resolves long-running patent litigation, reinforcing commitment to defend innovation29.5.2026 14:00:00 CEST | Press release
News summary: Non-practicing entity litigation continues to create costly, time-consuming pressure across the technology industry Adtran has reached a full settlement following counterclaims, with payment made to Adtran and all claims dismissed with prejudice Outcome reflects Adtran’s commitment to defend its innovations, customers and business against meritless patent assertions Adtran today announced it has resolved a patent litigation matter, resulting in a full settlement and dismissal of all claims with prejudice. The case, initiated in 2020 by a non-practicing entity asserting five patents, was transferred to the US District Court for the Northern District of Alabama in 2021 following a successful motion by Adtran. Adtran subsequently filed counterclaims, including bad-faith patent assertion under Alabama statutory law. The settlement includes payment to Adtran to resolve its counterclaims. Terms of the agreement remain confidential. “This outcome reflects a disciplined and consi
Meiji Seika Pharma Invests in GHIC’s Global Health Security Fund29.5.2026 13:00:00 CEST | Press release
Meiji Seika Pharma Co., Ltd. (Headquarters: Tokyo, Japan; President and Representative Director: Toshiaki Nagasato) today announced that it has committed to invest in the Global Health Security Fund (GHSF), which is sponsored by Global Health Investment Corporation (GHIC), a New York-based nonprofit organization. Through this investment, Meiji Seika Pharma will support the acceleration of innovations addressing critical global health challenges, including pandemic preparedness and antimicrobial resistance (AMR). GHIC is a mission‑driven nonprofit organization that deploys private investment strategies to generate both global health impact and financial returns. GHIC recently closed its second fund in GHSF. With more than a decade of experience investing in the field of infectious disease, GHIC has contributed to addressing major global health challenges. Its portfolio companies have successfully commercialized more than a dozen products, collectively reaching over 600 million people wo
IFF Enters Into Agreement to Sell Its Food Ingredients Business to CVC29.5.2026 12:50:00 CEST | Press release
Transaction advances portfolio transformation, sharpens focus on higher-growth, higher-margin businesses, strengthens balance sheet, and enhances value creation for shareholders IFF (NYSE: IFF), a global leader in flavors, fragrances, food ingredients, and health and biosciences, today announced that it has entered into an agreement to sell its Food Ingredients business to funds advised by CVC Capital Partners, a leading global private markets manager, in a transaction that values the business at approximately $4.3 billion, representing an enterprise value-to-EBITDA multiple of approximately 10x. As part of the transaction, IFF has chosen to retain an approximately 10% minority equity interest in the business, or approximately $200 million, permitting continued collaboration and cooperation between IFF and Food Ingredients and allowing IFF and its shareholders to participate in future value creation under its new ownership. The transaction marks a significant step in IFF’s portfolio tr
BeOne Medicines Establishes Standard for Long-Term Disease Control in CLL with BRUKINSA 78-Month Data at ASCO 202629.5.2026 12:00:00 CEST | Press release
Data represents the longest reported follow-up for a next-generation BTK inhibitor in CLL, showing sustained disease control and benefit that extends beyond first-line therapyBRUKINSA plus next-generation BCL2 inhibitor sonrotoclax (ZS) delivered deep, durable, and rapid uMRD responses, raising the bar for potential time-limited treatments in CLLData reinforce BeOne’s leadership in CLL and the strength of its foundational hematology franchise BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, is advancing the treatment paradigm in chronic lymphocytic leukemia (CLL) at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting. With extensive long-term follow-up, the SEQUOIA study of BRUKINSA® (zanubrutinib) reinforces its role as the foundational BTK inhibitor, showing sustained disease control over years of therapy. These findings are further supported by real-world evidence across three large analyses encompassing more than 250,000 pati
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom